United Therapeutics | UTHR - Market Capitalization

Stock Price
567.16
Daily Change
-5.69 -0.99%
Monthly
4.72%
Yearly
94.65%
Q2 Forecast
555.02

United Therapeutics reported $26.96B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amarin USD 290M 51M Dec/2025
Ardelyx USD 1.42B 89M Dec/2025
Baxter International USD 9.82B 1.87B Dec/2025
Bayer EUR 36.36B 9.13B Dec/2025
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Emergent BioSolutions USD 125M 51M Dec/2023
Esperion Therapeutics USD 885M 351M Dec/2025
Gilead Sciences USD 166.62B 14.34B Apr/2026
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
J&J USD 561.65B 17.5B Apr/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
PTC Therapeutics USD 5.26B 844M Apr/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025